Core--Monoclonal antibody

$340,869P30FY2009NSNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Paper 39713341 Paper 39656211 Paper 39574572 Paper 39484387 Paper 38821932 Paper 38743626 Paper 38589390 Paper 38573855 Paper 38434042 Paper 38327094 Paper 38235335 Paper 38185937 Paper 38015636 Paper 37697112 Paper 37645816 Paper 37599467 Paper 37368868 Paper 37293032 Paper 37292710 Paper 37259916 Paper 36584299 Paper 36384119 Paper 36171283 Paper 36103513 Paper 35914143 Paper 35654037 Paper 35264793 Paper 34863367 Paper 34738905 Paper 34607806 Paper 34362912 Paper 34128833 Paper 34106046 Paper 34049878 Paper 33951442 Paper 33912017 Paper 33908623 Paper 33906969 Paper 33891544 Paper 33731436 Paper 33721552 Paper 33689678 Paper 33400321 Paper 33303678 Paper 33300868 Paper 33226141 Paper 33186550 Paper 33151428 Paper 33140455 Paper 33095500 Paper 32873651 Paper 32375055 Paper 32202618 Paper 32047263 Paper 31975687 Paper 31932351 Paper 31913121 Paper 31812516 Paper 31564592 Paper 31533036 Paper 31467299 Paper 31402283 Paper 31128945 Paper 31036561 Paper 30992373 Paper 30657454 Paper 30647452 Paper 30626878 Paper 30270038 Paper 30184489 Paper 30077356 Paper 30076594 Paper 29847801 Paper 29643356 Paper 29628143 Paper 29625118 Paper 29596047 Paper 29556025 Paper 29555853 Paper 29381137 Paper 29320739 Paper 29267967 Paper 29154130 Paper 29055051 Paper 28940645 Paper 28821643 Paper 28720882 Paper 28663888 Paper 28632130 Paper 28485037 Paper 28434802 Paper 28392471 Paper 28285821 Paper 28223516 Paper 28217086 Paper 28153034 Paper 28132840 Paper 28103900 Paper 28069946 Paper 28059584

Abstract

The aim of the Monoclonal Antibody Core is to generate mouse and rat monoclonal antibodies against proteins studied by NINDS investigators at JHU SOM. Antibodies are central for the analysis of protein function, and ongoing studies by the Primary Center Investigators and other NINDS-funded investigators at the JHU SOM have been severely limited by the availability of reliable quantities of unique mono-specific antibodies. The monoclonal facility will develop new antibodies with enhanced selectivity, providing a much-needed resource to the Center's primary investigators and also other NINDS-funded scientists at JHU SOM. No such facility currently exists at JHU SOM.

View original record on NIH RePORTER →